Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
6.61
-0.38 (-5.44%)
At close: Jul 24, 2026, 4:00 PM EDT
6.30
-0.31 (-4.69%)
After-hours: Jul 24, 2026, 6:13 PM EDT

CPIX Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-44.5237.8739.5542.0135.99
Revenue Growth
-17.57%-4.26%-5.85%16.75%-3.89%
Gross Profit
-7.1837.8531.2833.4932.8927.17
Operating Income
-7.21-2.79-6.43-9.55-5.7-7.68
Net Income
-4.03-2.84-6.48-6.28-5.57-3.51
Earnings Per Share
-0.49-0.19-0.46-0.44-0.38-0.24
EPS Growth
------

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
39.6235.1738.4540.5133.79
China
2.98----
South Korea
1.321.49---
Russia
0.430.47---
Mexico
0.120.01---
Australia
0.030.05---
Saudi Arabia
0.010.65---
Other Outside The United States
0.010.04---
Total
44.5237.8739.5542.0135.99

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
11.0111.4417.9618.3219.7627.04
Total Debt
10.0710.1820.5718.4320.9616.06
Net Cash (Debt)
0.941.26-2.61-0.11-1.210.98
Net Cash Growth
-79.92%----43.03%
Net Cash Per Share
0.060.09-0.19-0.01-0.080.74

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1.424.93-0.616.098.456.34
Capital Expenditures
-0.05-0.1-0.07-0.28-0.1-0.1
Free Cash Flow
1.374.83-0.685.818.356.24
Free Cash Flow Growth
-74.38%---30.40%33.86%18.29%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-85.02%82.61%84.66%78.29%75.51%
Operating Margin
--6.27%-16.99%-24.16%-13.58%-21.34%
Pretax Margin
--6.31%-17.08%-15.89%-13.29%-15.46%
Profit Margin
--6.40%-17.02%-16.01%-13.45%-15.55%
FCF Margin
-10.86%-1.79%14.70%19.88%17.34%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-24.0024.0024.0024.0024.00
P/FCF Ratio
72.2512.31-4.353.8711.04
PS Ratio
2.361.340.870.640.771.91